These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7326694)

  • 1. Conclusion to be derived from in vitro data with respect to in vivo activity.
    Gotoh S
    Clin Ther; 1981; 4 Suppl A():8-17. PubMed ID: 7326694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intradiscal antibiotics for discography: an in vitro study of gentamicin, cefazolin, and clindamycin.
    Klessig HT; Showsh SA; Sekorski A
    Spine (Phila Pa 1976); 2003 Aug; 28(15):1735-8. PubMed ID: 12897501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of cefquinome against equine bacterial pathogens.
    Thomas E; Thomas V; Wilhelm C
    Vet Microbiol; 2006 Jun; 115(1-3):140-7. PubMed ID: 16455213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial properties of traditionally used Indian medicinal plants.
    Aqil F; Ahmad I
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):79-92. PubMed ID: 17440624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of war wound infection].
    Kucisec-Tepes N; Bejuk D; Kosuta D
    Acta Med Croatica; 2006 Sep; 60(4):353-63. PubMed ID: 17048790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The etiological structure of the causative agents of inflammatory nonspecific urological diseases and the dynamics of their resistance to the widely used antibiotics].
    Derevianko NI; Kotliarova GA; Kondrat'eva EM; Nefedova LA; Kudriashova EE
    Urol Nefrol (Mosk); 1997; (3):13-8. PubMed ID: 9245048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.
    Goldstein EJ; Citron DM; Vaidya SA; Warren YA; Tyrrell KL; Vreni Merriam C; Fernandez H
    Anaerobe; 2006 Apr; 12(2):63-6. PubMed ID: 16701615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
    Matthews SJ; Lancaster JW
    Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of Elaeagnus umbellata (Thunb.) a medicinal plant from Pakistan.
    Sabir MS; Ahmad DS; Hussain IM; Tahir KM
    Saudi Med J; 2007 Feb; 28(2):259-63. PubMed ID: 17268691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.
    Bradford PA; Weaver-Sands DT; Petersen PJ
    Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asparenomycins A, B and C, new carbapenem antibiotics. IV. Antibacterial activity.
    Kimura Y; Motokawa K; Nagata H; Kameda Y; Matsuura S; Mayama M; Yoshida T
    J Antibiot (Tokyo); 1982 Jan; 35(1):32-8. PubMed ID: 7068514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic management of bacterial bile-duct and gallbladder infections.
    Ujváry G; Küttel P; Lazaritis J
    Acta Chir Acad Sci Hung; 1975; 16(2):165-74. PubMed ID: 1227223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pyrazine-1,4-dioxides fused to heterocycles / 2nd comm.: Synthesis and antibacterial activity of substituted pyrido[2,3-b]pyrazine-1,4-dioxides (author's transl)].
    Binder D; Georgopoulos A; Noe CR; Nussbaumer J; Prager BC; Turnowsky F
    Arzneimittelforschung; 1982; 32(1):10-4. PubMed ID: 7199336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.